Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.075
-0.045 (-1.44%)
At close: Jul 17, 2026, 4:00 PM EDT
3.040
-0.035 (-1.14%)
After-hours: Jul 17, 2026, 4:54 PM EDT
Evaxion Market Cap
Evaxion has a market cap or net worth of $25.65 million as of July 17, 2026. Its market cap has increased by 54.67% in one year.
Market Cap
25.65M
Enterprise Value
7.21M
1-Year Change
54.67%
Ranking
Category
Stock Price
$3.08
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $25.65M, a decrease of -86.64%. That is a compound annual growth rate of -30.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 25.65M | -35.53% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 28.04M |
| Plus Therapeutics | 26.91M |
| Barinthus Biotherapeutics | 26.56M |
| GridAI Technologies | 26.01M |
| VYNE Therapeutics | 25.99M |
| IGC Pharma | 25.92M |
| NeuroSense Therapeutics | 24.79M |
| Polyrizon | 24.15M |